Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
about
Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemiaCongenital acute leukemia with initial indolent presentation--a case report.MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.The molecular mechanics of mixed lineage leukemia.Identification of somatic and germline mutations using whole exome sequencing of congenital acute lymphoblastic leukemia.Licensing and labelling of drugs in a paediatric oncology ward.Novel Cryptic Rearrangements in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Involving the MLL Gene.Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group.Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyondCCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements.Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemiaMLL-Rearranged Leukemias-An Update on Science and Clinical Approaches.MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL.The evolution of clinical trials for infant acute lymphoblastic leukemia.Congenital acute lymphoblastic leukemia: a two-case report and a review of the literature.Neonatal leukaemia cutis.Congenital B-lymphoblastic leukemia with a cryptic MLL rearrangement and post-treatment evolution to mixed phenotype acute leukemiaClinical and molecular epidemiology of neonatal leukemia in Brazil.NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial.Congenital acute lymphoblastic leukemia case with a novel t(2:4:11) (p21:q21:q23) translocation.
P2860
Q26783577-3BD2CB04-F602-40F1-93F8-285370F78B08Q33394246-905E6699-5F26-4D2C-9B54-E41310481640Q34060270-EC5B06B0-330D-442B-8141-CB7B29F4DB68Q34516051-91930080-E46E-4D6C-B68F-C550DE78CC54Q34573775-B3D2F48E-D8BD-415B-B832-AA89B5A9D392Q35219672-3BB5E281-7CD6-4E3C-A3A0-D2B3A67E0685Q35538663-033A3E01-E62F-4E5D-B9E1-435F4A8CED11Q35781265-C46592F1-9762-438E-8CEE-B272656BA5DBQ35967446-ADEF926B-C1EA-4263-8DDD-97122748A7F1Q36056038-B98DAFB1-2F16-4DA4-9B26-4E9F31D9958EQ36892604-2074B74A-1A99-4472-A145-9C0058CE3FC4Q37633532-76547C69-4462-41C0-BD14-C027023F2FC9Q37633585-572F5D14-BABB-4AF8-A26F-EFF6E74F69BDQ37692596-79A38BD9-08C5-4FB3-BF38-156EA6F3C2F2Q37730023-16C52AC3-F592-4709-8E8B-0C75F513DC1AQ37806676-4CA52A2D-54F3-47C9-BF9B-8B17159FAB8AQ38410225-D49DD325-188F-45D5-A26F-DF300F657D94Q41929255-C7A45080-E749-4856-BD8F-B5033005D845Q44833746-B9D1C979-27C4-4588-9265-27E11671C9B4Q47930875-188881CA-1C26-4D5A-B6B2-B1AA93EF1418Q51515979-B1AEC9CF-8833-4890-B80F-3C2AE9F0D58FQ54538463-265ED7C1-ACE1-414F-9B25-E7938E75D459
P2860
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
@en
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
@nl
type
label
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
@en
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
@nl
prefLabel
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
@en
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
@nl
P2093
P1433
P1476
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.
@en
P2093
Alina Ferster
Andrea Biondi
Anja Möricke
Gritta Janka
Jeffrey E Rubnitz
Lewis B Silverman
Liisa Hovi
P304
P356
10.1182/BLOOD-2009-02-204214
P407
P577
2009-08-05T00:00:00Z